Covered recipient · General Payments record
MARY L GRAEFF
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2022
$306.46
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $145.28 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $25.86 | 2 |
| Abbott Laboratories | $23.10 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.93 | 1 |
| Amgen Inc. | $15.77 | 1 |
| Novo Nordisk AS | $15.47 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.19 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.98 | 1 |
| Lilly USA, LLC | $11.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.10 | 11/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908620219 | CMS |
| Amgen Inc. | $15.77 | 07/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939461363 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $15.19 | 02/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 930271283 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.93 | 05/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 887695313 | CMS |
| Lilly USA, LLC | $11.98 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918193521 | CMS |
| Merck Sharp & Dohme LLC | $12.44 | 04/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944292359 | CMS |
| Merck Sharp & Dohme LLC | $13.42 | 11/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944261991 | CMS |
| Novo Nordisk Inc | $15.47 | 06/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899454159 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.98 | 01/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 959511533 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.